Additional Information

Description

Triazolam 0.25 mg tablets are formulated for the short-term treatment of insomnia, particularly in cases where difficulty in falling asleep or frequent awakenings during the night are experienced. These tablets are light-grayish blue in color and elliptical in shape, offering an easily identifiable form for accurate dosing. Each tablet is imprinted with the code "12" on one side and "89" on the other, facilitating clear identification and ensuring proper usage.

The active ingredient in these tablets, triazolam, belongs to the benzodiazepine class of medications. Triazolam exerts its therapeutic effects by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits activity in the brain. This action helps to induce a calming effect, promoting the onset of sleep and maintaining its duration, which is beneficial for individuals suffering from acute insomnia.

Triazolam tablets are intended for oral administration, with a recommended dosage individualized based on the patient's response and medical condition. Typically prescribed for short-term use, this medication effectively addresses sleep disturbances without the risk of dependency associated with long-term use. Proper adherence to the prescribed regimen is essential to avoid potential side effects and ensure the medication's efficacy.